BioGaia Reports 9% Sales Growth in 2016

a10c9b81-d886-4137-9cda-f4a798f3ec08articleimage.jpg

14 Feb 2017 --- Swedish probiotics manufacturer, BioGaia, has announced an annual sales growth of 9% in 2016 - a growth that the company is in part attributing to its continued success in the Asian market.

The company’s net sales amounted to SEK 534.7 million ($60 million) in 2016.

“Looking back at 2016, we can only feel satisfied,” says Axel Sjöblad, Managing Director of BioGaia AB.

“With sales growth of 9% excluding foreign exchange effects, we were able to pass the half billion mark and achieve annual sales of SEK 534.7 million ($60 million).”

“This enabled us to increase our market shares despite the fact that the sales to Brazil, one of our most important markets, were low as a result of the inventory build-up during 2015.”

“The operating profit, excluding the distributed former subsidiary IBT, reached SEK 199.4 million ($22.4 million), an increase of 14% excluding foreign exchange effects, which leads to an operating margin of 37%.”

“Our strong financial development, while we were building a platform for future growth and signing new distribution agreements in Japan and Thailand, demonstrates the strength of our business model, our employees and our products, and gives us reason to look to the future with continued confidence.”

Towards the end of Q4, BioGaia signed major agreements for the sale of BioGaia’s probiotic products in Japan, and the company also made a further investment in MetaboGen, a company researching the microbiome to understand health and disease, and creating opportunities to develop novel therapeutics and next generation probiotics.

And it looks like the year ahead is set to follow in 2016’s footsteps. So far in 2017, an agreement has been made for the sale of BioGaia’s products in Thailand, with the products being co-branded under BioGaia and Abbott brand.

“We have a strong focus on growing our Asian business and I am very pleased that BioGaia’s products will be available in another important country in the region,” says Axel Sjöblad.

“Based on the positive experience we already have in collaborating with Abbott in Latin America, I look forward to a successful launch of our products with Abbott in Thailand as well.”

Related Articles

Nutrition & Health News

“Unhelpful”: EU regulatory framework fuels nutrition industry dissatisfaction 

16 Feb 2018 --- A survey reveals that one-third of all nutrition industry professionals believe that the current EU framework for achieving a health claim on new products is stunting innovation because it’s complicated, expensive, long-winded and has several “gray areas.” And “regulation frustration” is a strong feeling running through the industry with many more professionals now believing the current EU regulatory environment is “unhelpful” – a 25 percent hike compared with statistics from the beginning of 2017. Experts are attributing this sharp rise in dissatisfaction to the EU’s tough stance on health claims and the current regulatory deadlock on botanicals.

Nutrition & Health News

Indulgence has reached even America’s healthiest eaters: research

16 Feb 2018 --- New research reveals even the US’ healthiest eaters reach for indulgence foods based on their emotional states. Forty percent of US food-brand lovers who rated their daily diet as extremely healthy agreed with the statement, “When I’m feeling down, I eat something indulgent to make me feel better.” The study, conducted by full-service food branding agency, Foodmix Marketing Communications, breaks out a large group of brand lovers into smaller, differentiated and more actionable consumer segments.  

Nutrition & Health News

Research driving demand for OPO in China’s formula market: Advanced Lipids

16 Feb 2018 --- OPO is increasing in popularity in China’s infant formula market, and according to Advanced Lipids, this is down to the growing body of scientific research backing the benefits of this ingredient. Also known as SN-2 palmitate, OPO is a premium quality ingredient that mimics the fatty acid profile of human milk.

Nutrition & Health News

Lactose-free dairy: DSM to market cost-effective analyzer

16 Feb 2018 --- February 2018, DSM will exclusively market BIOMILK 300, a compact residual lactose-analyzing device produced by Biolan. For dairy producers, the BIOMILK 300 is a fast, cost-effective and accurate analyzer for quantifying residual lactose levels in lactose-free and lactose-reduced dairy products.

Business News

Natures Crops, De Wit Speciality Oils enter into European distribution partnership for Ahiflower oil

15 Feb 2018 --- Natures Crops International and De Wit Speciality Oils have entered into a distribution agreement for Ahiflower oil in the European dietary supplement marketplace. This alliance is thought to add strategic value for both companies through each company’s leading position in manufacturing and marketing nutraceutical products.

More Articles
URL : http://www.nutritioninsight.com:80/news/BioGaia-Reports-9-Sales-Growth-in-2016.html?tracking=Nutrition%20and%20Health%20News